Biopharmaceutical Testing by Product Category | Charles River

vaccines 

Charles River offers multiple products and services in support of the development, manufacture and analytical testing of vaccines. Our Biopharmaceutical Services group has experience in the manufacture of live and attenuated viral vaccines in both cell- and egg-based expression systems under current Good Manufacturing Practice (cGMP) requirements for both preclinical studies and early-phase clinical trials. We offer testing from release of cell banks and viral stocks to the release of bulk and final vaccine product.

Testing Services


To check which of our BPS facilities perform vaccine testing, click here.

Related Information

For a copy of our Preclinical Vaccine Researcher newsletter and access to our archived vaccine webinars, please log in to The SourceSM. If you are not a member of The SourceSM, our new online scientific and educational information center, please click here to register.

For more information on our capabilities that help support the development and commercialization of vaccines, contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.